TheraVet provides an update on its 2023 half-year development and portfolio strategy
GOSSELIES, Belgium, July 11, 2023--Regulatory News: TheraVet (ISIN: BE0974387194 - ticker: ALVET) (Paris:ALVET) (Brussels:ALVET), a pioneering company in the management of osteoarticular diseases in companion animals, provides the half-year update on its development strategy.
Source: yahoo.com